Literature DB >> 16797070

Identification of PML-RARA rearrangement by RT-PCR and sequencing in an acute promyelocytic leukemia without t(15;17) on G-banding and FISH.

Jin-Yeong Han1, Kyong-Eun Kim, Kyeong-Hee Kim, Joo-In Park, Jae-Seok Kim.   

Abstract

Acute promyelocytic leukemia (APL) is characterized by a reciprocal translocation, t(15;17) (q22;q12), resulting in fusion of the genes promyelocytic leukemia (PML) and retinoic acid receptor alpha (RARA). With conventional cytogenetic methods, these translocations are detected in about 70-90% of patients, with most of the negative results due to technical problems or cryptic variants. Those masked PML-RARA fusions can be identified by molecular analyses such as reverse transcriptase-polymerase chain reaction (PCR) and fluorescence in situ hybridization (FISH). We have studied a patient showing morphological, cytochemical, and immunophenotypic features of hypergranular APL with trisomy 8 as a sole anomaly. t(15;17) was not evident on FISH tests, while RT-PCR and cDNA sequencing revealed the presence of PML-RARA transcripts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16797070     DOI: 10.1016/j.leukres.2006.05.011

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

1.  A PML/RARA chimeric gene on chromosome 12 in a patient with acute promyelocytic leukemia (M4) associated with a new variant translocation: t(12;15;17)(q24;q24;q11).

Authors:  Ayda Bennour; Ikram Tabka; Yosra Ben Youssef; Monia Zaier; Sondess Hizem; Abderrahim Khelif; Ali Saad; Halima Sennana
Journal:  Med Oncol       Date:  2013-01-06       Impact factor: 3.064

2.  Characteristics features and factors influencing early death in Acute promyelocytic leukemia; Experience from United Arab Emirates (UAE).

Authors:  Inaam Bashir Hassan; Mariam R Al Zaabi; Arif Alam; Mohammed Jawad Hashim; Martin S Tallman; Jorgen Kristensen
Journal:  Int J Hematol       Date:  2017-03-14       Impact factor: 2.490

3.  Multiple cranial neuropathy and intracranial hypertension associated with all-trans retinoic acid treatment in a young adult patient with acute promyelocytic leukemia.

Authors:  J Labrador; N Puig; A Ortín; N C Gutierrez; M González-Díaz
Journal:  Int J Hematol       Date:  2012-07-06       Impact factor: 2.490

4.  Cytogenetically cryptic PML::RARA fusion in acute promyelocytic leukemia: Testing strategies in the modern era.

Authors:  Kirill Karlin; Christine Bryke; Ajoy Dias; Phillip Michaels
Journal:  Leuk Res Rep       Date:  2022-05-04

5.  High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based Regimen.

Authors:  Zeba N Singh; Vu H Duong; Rima Koka; Ying Zou; Sameer Sawhney; Li Tang; Maria R Baer; Nicholas Ambulos; Firas El Chaer; Ashkan Emadi
Journal:  J Hematop       Date:  2018-08-09       Impact factor: 0.196

6.  Identification of a new cryptic PML-RARα fusion gene without t(15;17) and biallelic CEBPA mutation in a case of acute promyelocytic leukemia: a case detected only by RT-PCR but not cytogenetics and FISH.

Authors:  Zhanglin Zhang; Yawen Xu; Mei Jiang; Fancong Kong; Zhiwei Chen; Shuyuan Liu; Fei Li
Journal:  Cancer Biol Ther       Date:  2020-01-20       Impact factor: 4.742

7.  Rapid detection of prognostically significant fusion transcripts in acute leukemia using simplified multiplex reverse transcription polymerase chain reaction.

Authors:  Young-Uk Cho; Hyun-Sook Chi; Chan-Jeoung Park; Seongsoo Jang; Eul-Ju Seo
Journal:  J Korean Med Sci       Date:  2012-10-02       Impact factor: 2.153

8.  Detection of promyelocytic leukemia/retinoic acid receptor α (PML/RARα) fusion gene with functionalized graphene oxide.

Authors:  Ran Li; Yanhong Tan; Xiuhua Chen; Fanggang Ren; Yaofang Zhang; Zhifang Xu; Hongwei Wang
Journal:  Int J Mol Sci       Date:  2013-06-20       Impact factor: 5.923

9.  t(15; 17) associated with primary myelofibrosis: a case report of an unusual clinical presentation and diagnostic dilemma.

Authors:  Kalyan Nadiminti; Margarida Silverman; Sharathkumar Bhagavathi; Praveen Vikas
Journal:  Onco Targets Ther       Date:  2019-07-11       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.